Cargando…

Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma

Interference with inhibitory immunological checkpoints controlling T cell activation provides new opportunities to augment cancer immunotherapies. Whereas cytotoxic T lymphocyte–associated antigen-4 blockade has shown promising preclinical and clinical results, therapeutic CD4(+)CD25(+) T reg cell d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quezada, Sergio A., Peggs, Karl S., Simpson, Tyler R., Shen, Yuelei, Littman, Dan R., Allison, James P.
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2008
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2526206/ https://www.ncbi.nlm.nih.gov/pubmed/18725522 http://dx.doi.org/10.1084/jem.20080099

Ejemplares similares

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
por: Simpson, Tyler R., et al.
Publicado: (2013)

Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
por: Quezada, Sergio A., et al.
Publicado: (2010)

Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
por: Peggs, Karl S., et al.
Publicado: (2009)

CD25-T(reg)-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity
por: Solomon, Isabelle, et al.
Publicado: (2020)

Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors
por: Arce Vargas, Frederick, et al.
Publicado: (2017)

Tumor masses support naive T cell infiltration, activation, and differentiation into effectors
por: Thompson, Elizabeth D., et al.
Publicado: (2010)

Eradication of established human melanoma tumors in nude mice by antibody-directed effector cells
Publicado: (1985)

Depletion of B220(+)NK1.1(+) cells enhances the rejection of established melanoma by tumor-specific CD4(+) T cells
por: Wilson, Kyle A, et al.
Publicado: (2015)

Activity of murine surrogate antibodies for durvalumab and tremelimumab lacking effector function and the ability to deplete regulatory T cells in mouse models of cancer
por: Schofield, Darren J., et al.
Publicado: (2021)

Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells
por: Tanaka, Atsushi, et al.
Publicado: (2019)

Pancreatic Ductal Adenocarcinoma Contains an Effector and Regulatory Immune Cell Infiltrate that Is Altered by Multimodal Neoadjuvant Treatment
por: Shibuya, Kendall C., et al.
Publicado: (2014)

CD4 expression in effector T cells depends on DNA demethylation over a developmentally established stimulus-responsive element
por: Teghanemt, Athmane, et al.
Publicado: (2022)

A heat-shocked melanoma cell lysate vaccine enhances tumor infiltration by prototypic effector T cells inhibiting tumor growth
por: Gleisner, María Alejandra, et al.
Publicado: (2020)

Functional Analysis of Mononuclear Cells Infiltrating into Tumors: Establishment of a New System to Obtain Functionally Active Tumor‐infiltrating Cells
por: Shijubo, Noriharu, et al.
Publicado: (1990)

Addressing the Elephant in the Immunotherapy Room: Effector T-Cell Priming versus Depletion of Regulatory T-Cells by Anti-CTLA-4 Therapy
por: Hong, Megan M Y, et al.
Publicado: (2022)

CD27 Promotes Survival of Activated T Cells and Complements CD28 in Generation and Establishment of the Effector T Cell Pool
por: Hendriks, Jenny, et al.
Publicado: (2003)

Activation of myeloid dendritic cells, effector cells and regulatory T cells in lichen planus
por: Domingues, Rosana, et al.
Publicado: (2016)

Single-cell transcriptomics reveals distinct effector profiles of infiltrating T cells in lupus skin and kidney
por: Dunlap, Garrett S., et al.
Publicado: (2022)

Intratumoral immune activation with TLR4 agonist synergizes with effector T cells to eradicate established murine tumors
por: Albershardt, Tina C., et al.
Publicado: (2020)

Neoantigen-specific CD4(+) tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients
por: Hall, MacLean S., et al.
Publicado: (2023)

Local delivery of CpG-B and GM-CSF induces concerted activation of effector and regulatory T cells in the human melanoma sentinel lymph node
por: van den Hout, Mari F. C. M., et al.
Publicado: (2016)

Transient T cell depletion causes regression of melanoma metastases
por: Rasku, Mary Ann, et al.
Publicado: (2008)

Distinct integrin activation pathways for effector and regulatory T cell trafficking and function
por: Sun, Hao, et al.
Publicado: (2020)

Melanoma cell-derived exosomes in plasma of melanoma patients suppress functions of immune effector cells
por: Sharma, Priyanka, et al.
Publicado: (2020)

Depletion of Regulatory T Cells Augments a Vaccine-Induced T Effector Cell Response against the Liver-Stage of Malaria but Fails to Increase Memory
por: Espinoza Mora, Maria del Rosario, et al.
Publicado: (2014)

Activation of melanocortin-1 receptor signaling in melanoma cells impairs T cell infiltration to dampen antitumor immunity
por: Cui, Yazhong, et al.
Publicado: (2023)

Cyclophosphamide depletes tumor infiltrating T regulatory cells and combined with anti-PD-1 therapy improves survival in murine neuroblastoma
por: Webb, Emily R., et al.
Publicado: (2022)

Human Regulatory T Cell Suppressive Function Is Independent of Apoptosis Induction in Activated Effector T Cells
por: Vercoulen, Yvonne, et al.
Publicado: (2009)

Regulatory T cells suppress CD4(+) effector T cell activation by controlling protein synthesis
por: So, Lomon, et al.
Publicado: (2023)

Hypoxia Is a Dominant Remodeler of the Effector T Cell Surface Proteome Relative to Activation and Regulatory T Cell Suppression
por: Byrnes, James R., et al.
Publicado: (2022)

Transcription factor RORα enforces stability of the Th17 cell effector program by binding to a Rorc cis-regulatory element
por: Hall, Jason A., et al.
Publicado: (2022)

Regulatory and activated effector T cells in chronic hepatitis C virus: Relation to autoimmunity
por: Fouad, Hanan, et al.
Publicado: (2016)

Phase II trial of the regulatory T cell-depleting agent, denileukin diftitox, in patients with unresectable stage IV melanoma
por: Telang, Sucheta, et al.
Publicado: (2011)

Pro-Invasive Activity of the Hippo Pathway Effectors YAP and TAZ in Cutaneous Melanoma
por: Nallet-Staub, Flore, et al.
Publicado: (2014)

Itk and Fyn Make Independent Contributions to T Cell Activation
por: Liao, X. Charlene, et al.
Publicado: (1997)

A novel program of infiltrative control in astrocytomas: ADAM23 depletion promotes cell invasion by activating γ-secretase complex
por: Jandrey, Elisa Helena Farias, et al.
Publicado: (2023)

Lineage Tracking the Generation of T Regulatory Cells From Microbial Activated T Effector Cells in Naïve Mice
por: Zhu, Kun, et al.
Publicado: (2020)

Migratory Pulmonary Infiltrates in a B-Cell-Depleted COVID-19 Patient
por: Zhu, Wenyan, et al.
Publicado: (2023)

Dietary restriction and other lifespan extending pathways converge at the activation of the downstream effector takeout
por: Gáliková, Martina, et al.
Publicado: (2010)

Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma
por: Ghorani, E, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ufl9hcuh1ksgpjbifcr1imdh1c